ESP Pharma Inc.
This article was originally published in Start Up
Executive Summary
In the black since the day it opened its doors in April 2002, ESP Pharma Inc. is pursuing a buy-and-build approach. Targeting the acute-care hospital market, it is creating new dosages and seeking new indications for its rapidly expanding pipeline.